NYSE:LLY - Eli Lilly And Co News Headlines

Sign in or create an account to add this stock to your watchlist.
$90.08 +0.51 (+0.57 %)
(As of 07/18/2018 04:00 PM ET)
Previous Close$89.50
Today's Range$89.11 - $90.12
52-Week Range$73.69 - $89.97
Volume216,590 shs
Average Volume2.86 million shs
Market Capitalization$96.68 billion
P/E Ratio20.91
Dividend Yield2.53%
Beta0.25

Headlines

Eli Lilly And Co (NYSE LLY) News Headlines

Source:
DateHeadline
Pfizer And Lilly Announce Positive Results From Phase 3 Trial Of TanezumabPfizer And Lilly Announce Positive Results From Phase 3 Trial Of Tanezumab
www.nasdaq.com - July 18 at 8:23 AM
Pfizer and Lillys tanezumab successful in late-stage osteoarthritis pain studyPfizer and Lilly's tanezumab successful in late-stage osteoarthritis pain study
seekingalpha.com - July 18 at 8:23 AM
Pfizer And Lilly Announce Positive Top-Line Results From Phase 3 Trial Of Tanezumab For The Treatment Of Osteoarthritis (OA) PainPfizer And Lilly Announce Positive Top-Line Results From Phase 3 Trial Of Tanezumab For The Treatment Of Osteoarthritis (OA) Pain
finance.yahoo.com - July 18 at 8:23 AM
Pfizer-Lilly pain drug found effective in late-stage studyPfizer-Lilly pain drug found effective in late-stage study
finance.yahoo.com - July 18 at 8:23 AM
Eli Lilly And Co (LLY) Given "Buy" Rating at Cantor FitzgeraldEli Lilly And Co (LLY) Given "Buy" Rating at Cantor Fitzgerald
www.americanbankingnews.com - July 17 at 6:46 PM
Eli Lilly And Co (LLY) Price Target Raised to $90.00 at Bank of AmericaEli Lilly And Co (LLY) Price Target Raised to $90.00 at Bank of America
www.americanbankingnews.com - July 17 at 2:38 PM
Eli Lilly And Co (LLY) Scheduled to Post Earnings on TuesdayEli Lilly And Co (LLY) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - July 17 at 1:56 AM
Analyst Recommendations for Valeant Pharmaceuticals in JulyAnalyst Recommendations for Valeant Pharmaceuticals in July
finance.yahoo.com - July 16 at 4:40 PM
Jefferies Financial Group Analysts Give Eli Lilly And Co (LLY) a $100.00 Price TargetJefferies Financial Group Analysts Give Eli Lilly And Co (LLY) a $100.00 Price Target
www.americanbankingnews.com - July 16 at 9:52 AM
Credit Suisse Group Analysts Give Eli Lilly And Co (LLY) a $84.00 Price TargetCredit Suisse Group Analysts Give Eli Lilly And Co (LLY) a $84.00 Price Target
www.americanbankingnews.com - July 15 at 4:34 AM
New Lilly Diabetes helpline to Assist People Seeking Solutions to Insulin AffordabilityNew Lilly Diabetes helpline to Assist People Seeking Solutions to Insulin Affordability
finance.yahoo.com - July 12 at 8:30 AM
Rimidi Closes $6.575 Million Series A with Strategic Investment from Eli LillyRimidi Closes $6.575 Million Series A with Strategic Investment from Eli Lilly
www.bizjournals.com - July 11 at 8:25 AM
Zacks: Brokerages Expect Eli Lilly And Co (LLY) Will Announce Quarterly Sales of $6.10 BillionZacks: Brokerages Expect Eli Lilly And Co (LLY) Will Announce Quarterly Sales of $6.10 Billion
www.americanbankingnews.com - July 11 at 1:48 AM
Highmark, pharmaceutical company reach deal on diabetes drugHighmark, pharmaceutical company reach deal on diabetes drug
www.bizjournals.com - July 10 at 4:50 PM
Eli Lilly And Co (LLY) Given a $100.00 Price Target at Cantor FitzgeraldEli Lilly And Co (LLY) Given a $100.00 Price Target at Cantor Fitzgerald
www.americanbankingnews.com - July 10 at 10:28 AM
 Brokerages Anticipate Eli Lilly And Co (LLY) Will Post Earnings of $1.34 Per Share Brokerages Anticipate Eli Lilly And Co (LLY) Will Post Earnings of $1.34 Per Share
www.americanbankingnews.com - July 9 at 4:14 PM
Biogen Shares Soar on Positive Alzheimers Drug ResultsBiogen Shares Soar on Positive Alzheimer's Drug Results
www.thestreet.com - July 7 at 4:36 PM
Eli Lilly And Co (LLY) Major Shareholder Sells $14,725,400.00 in StockEli Lilly And Co (LLY) Major Shareholder Sells $14,725,400.00 in Stock
www.americanbankingnews.com - July 6 at 12:12 PM
Developments for Eli Lilly in June Include EASE Phase 3 DataDevelopments for Eli Lilly in June Include EASE Phase 3 Data
finance.yahoo.com - July 3 at 9:06 AM
Eli Lilly And Co (LLY) Receives Consensus Recommendation of "Hold" from AnalystsEli Lilly And Co (LLY) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - July 2 at 7:08 PM
Eli Lilly’s Animal Health BusinessEli Lilly’s Animal Health Business
finance.yahoo.com - July 2 at 4:36 PM
Analysts’ Estimates and Recommendations for Eli Lilly in JuneAnalysts’ Estimates and Recommendations for Eli Lilly in June
finance.yahoo.com - July 2 at 4:36 PM
Eli Lilly’s Cardiovascular Product PortfolioEli Lilly’s Cardiovascular Product Portfolio
finance.yahoo.com - July 2 at 8:41 AM
Blog Exposure - Eli Lillys Taltz(R) Meets Primary Endpoint in Phase-3 Study for Treatment of Ankylosing SpondylitisBlog Exposure - Eli Lilly's Taltz(R) Meets Primary Endpoint in Phase-3 Study for Treatment of Ankylosing Spondylitis
finance.yahoo.com - July 2 at 8:41 AM
Eli Lilly’s Oncology Product PortfolioEli Lilly’s Oncology Product Portfolio
finance.yahoo.com - June 30 at 8:28 AM
Lilly's (LLY) Taltz Positive in Ankylosing Spondylitis StudyLilly's (LLY) Taltz Positive in Ankylosing Spondylitis Study
finance.yahoo.com - June 30 at 8:28 AM
Lilly (LLY) Initiates Observational Survey of Epidemiology, Treatment and Care of MigraineLilly (LLY) Initiates Observational Survey of Epidemiology, Treatment and Care of Migraine
www.streetinsider.com - June 29 at 9:28 AM
Lilly Confirms Date and Conference Call for Second-Quarter 2018 Financial Results AnnouncementLilly Confirms Date and Conference Call for Second-Quarter 2018 Financial Results Announcement
finance.yahoo.com - June 29 at 9:28 AM
Eli Lilly’s Human Pharmaceuticals BusinessEli Lilly’s Human Pharmaceuticals Business
finance.yahoo.com - June 29 at 9:28 AM
LLY Announces Results for Emgality in Episodic Cluster HeadachesLLY Announces Results for Emgality in Episodic Cluster Headaches
finance.yahoo.com - June 29 at 9:28 AM
Lilly Announces Initiation of the Observational Survey of the Epidemiology, Treatment and Care of Migraine (OVERCOME) to Advance Understanding of Burden, Impact and Epidemiology of MigraineLilly Announces Initiation of the Observational Survey of the Epidemiology, Treatment and Care of Migraine (OVERCOME) to Advance Understanding of Burden, Impact and Epidemiology of Migraine
finance.yahoo.com - June 29 at 9:28 AM
Eli Lilly’s Neuroscience Product PortfolioEli Lilly’s Neuroscience Product Portfolio
finance.yahoo.com - June 29 at 9:28 AM
Eli Lily Highlights Study Results of Emgality for MigrainesEli Lily Highlights Study Results of Emgality for Migraines
finance.yahoo.com - June 29 at 9:28 AM
Eli Lilly reports positive results in trial of treatment for Ankylosing SpondylitisEli Lilly reports positive results in trial of treatment for Ankylosing Spondylitis
www.marketwatch.com - June 28 at 9:31 AM
Eli Lilly’s Q1 2018 Top Line Rose 9% to $5.7 BillionEli Lilly’s Q1 2018 Top Line Rose 9% to $5.7 Billion
finance.yahoo.com - June 28 at 9:31 AM
The Zacks Analyst Blog Highlights: Amazon, Intel, Eli Lilly, Illinois Tool Works and SouthernThe Zacks Analyst Blog Highlights: Amazon, Intel, Eli Lilly, Illinois Tool Works and Southern
finance.yahoo.com - June 28 at 9:31 AM
Eli Lilly’s Business Segments: Growth and TrendsEli Lilly’s Business Segments: Growth and Trends
finance.yahoo.com - June 28 at 9:31 AM
AHS 2018: Lilly Highlights Positive Phase 3 Results from the Largest Controlled Preventive Trial in Episodic Cluster HeadacheAHS 2018: Lilly Highlights Positive Phase 3 Results from the Largest Controlled Preventive Trial in Episodic Cluster Headache
finance.yahoo.com - June 27 at 5:41 PM
Top Research Reports for Amazon, Intel & Eli LillyTop Research Reports for Amazon, Intel & Eli Lilly
finance.yahoo.com - June 27 at 5:41 PM
A Look at Eli Lilly’s Valuations on June 25A Look at Eli Lilly’s Valuations on June 25
finance.yahoo.com - June 27 at 5:41 PM
AHS 2018: Lillys Emgality™ (galcanezumab-gnlm) Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed BOTOX®* (onabotulinumtoxinA)AHS 2018: Lilly's Emgality™ (galcanezumab-gnlm) Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed BOTOX®* (onabotulinumtoxinA)
finance.yahoo.com - June 27 at 5:41 PM
Eli Lilly & Co. (LLY) and Boehringer Ingelheim Announce Update from Two New Analyses from EMPA-REG OUTCOME Trial,Eli Lilly & Co. (LLY) and Boehringer Ingelheim Announce Update from Two New Analyses from EMPA-REG OUTCOME Trial,
www.streetinsider.com - June 26 at 9:27 AM
Eli Lilly To Present Phase 3 Data For Galcanezumab, Lasmiditan - Quick FactsEli Lilly To Present Phase 3 Data For Galcanezumab, Lasmiditan - Quick Facts
www.nasdaq.com - June 25 at 9:18 AM
Boehringer Ingelheim & Eli Lilly: Empagliflozin Trials Meet Primary EndpointBoehringer Ingelheim & Eli Lilly: Empagliflozin Trials Meet Primary Endpoint
www.nasdaq.com - June 25 at 9:18 AM
Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetesBoehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes
finance.yahoo.com - June 25 at 9:18 AM
Lilly to Present Phase 3 Data at AHS 2018 Highlighting Innovative Potential Treatments for Migraine and Cluster HeadacheLilly to Present Phase 3 Data at AHS 2018 Highlighting Innovative Potential Treatments for Migraine and Cluster Headache
finance.yahoo.com - June 25 at 9:18 AM
First-ever Study of Lillys Humulin® R U-500 Administered in an Insulin Pump Shows Improved A1C in People with Type 2 DiabetesFirst-ever Study of Lilly's Humulin® R U-500 Administered in an Insulin Pump Shows Improved A1C in People with Type 2 Diabetes
finance.yahoo.com - June 25 at 9:18 AM
Lillys Jardiance meets main goal of two diabetes trialsLilly's Jardiance meets main goal of two diabetes trials
finance.yahoo.com - June 25 at 9:18 AM
Eli Lilly and Company (NYSE:LLY) Is Trading At A 23.26% DiscountEli Lilly and Company (NYSE:LLY) Is Trading At A 23.26% Discount
finance.yahoo.com - June 24 at 6:29 PM
5 Biggest Blockbuster Diabetes Drugs of the Future5 Biggest Blockbuster Diabetes Drugs of the Future
finance.yahoo.com - June 24 at 9:06 AM
This page was last updated on 7/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.